CIK 0000882095
- Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943047598
- Phone
- +1 650-574-3000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $36,996,096
- in 12 filings, $37.0M under 10b5-1 plans
Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-15 | Mercier Johanna Chief Commercial Officer | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −700 | 110,610 | ||
| 2025-08-15 | Mercier Johanna Chief Commercial Officer | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −11,800 | 98,810 | ||
| 2025-08-15 | Mercier Johanna Chief Commercial Officer | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −700 | 98,110 | ||
| 2025-07-28 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −1,655 | $113.17 | $187K | 614,070 |
| 2025-07-28 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −8,345 | $114.09 | $952K | 605,725 |
| 2025-07-25 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise | +514 | 38,315 | ||
| 2025-07-25 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise | +8,229 | 46,544 | ||
| 2025-07-25 | Telman Deborah H EVP, Corporate Affairs & GC | Shares withheld for taxes | −3,823 | $116.20 | $444K | 42,721 |
| 2025-07-25 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise · Restricted Stock Unit | −514 | 29,875 | ||
| 2025-07-25 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise · Restricted Stock Unit | −8,229 | 21,646 | ||
| 2025-07-15 | Mercier Johanna Chief Commercial Officer | Sale 10b5-1 | −3,000 | $111.03 | $333K | 117,168 |
| 2025-07-15 | Dickinson Andrew D Chief Financial Officer | Sale 10b5-1 | −2,500 | $111.03 | $278K | 162,610 |
| 2025-07-14 | Bluestone Jeffrey Director | Option exercise 10b5-1 | +5,000 | $67.45 | $337K | 13,920 |
| 2025-07-14 | Bluestone Jeffrey Director | Sale 10b5-1 | −5,000 | $109.74 | $549K | 8,920 |
| 2025-07-14 | Bluestone Jeffrey Director | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −5,000 | 9,665 | ||
| 2025-06-30 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −9,400 | $110.40 | $1.0M | 616,325 |
| 2025-06-30 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −600 | $111.15 | $67K | 615,725 |
| 2025-06-16 | Dickinson Andrew D Chief Financial Officer | Sale 10b5-1 | −2,500 | $110.17 | $275K | 165,110 |
| 2025-06-16 | Mercier Johanna Chief Commercial Officer | Sale 10b5-1 | −3,000 | $110.17 | $331K | 120,168 |
| 2025-06-10 | Wilfong Diane E. Interim Corp Controller & CAO | Option exercise | +920 | 46,016 |
Page 15 of 30 · 599 trades